Dr. Anthony Yeung, Principal Investigator in the study, along with investigators Dr. Christopher Yeung and Dr. Justin Field, participated in this clinical trial that led to this FDA approval.
DISC, the only site in Arizona involved in this trial, was in the top 5 sites whose data was used for papers presented to national and international meetings authored by Josh Auerbach.
The 1st Comparative Effectiveness Study For the Treatment Of Spinal Stenosis
New York, NY, October 17, 2012 – Paradigm Spine LLC, a provider of innovative spinal implant technologies, announces the U.S. Food and Drug Administration (“FDA”) has granted a Premarket Approval (“PMA”) Order for coflex®, a minimally invasive, Motion Preserving Interlaminar Stabilization™ device for the treatment of Moderate To Severe Stenosis With Or Without Back Pain™.
Continue reading: “COFLEX® INTERLAMINAR TECHNOLOGY PRESS RELEASE” »
Interested in Learning More?
Download and read the complete study, procedure, and findings provided by Paradigm Spine®
“coflex®: Challenging the Gold Standard” »
LEADERS IN MINIMALLY INVASIVE SPINE CARE
1635 E. Myrtle • Suite 400 • Phoenix, AZ 85020
Ph: 602-944-2900 • Fax: 602-944-0064